62 indexable Life Sciences Platforms and Tools companies headquartered in North Rhine Westphalia, Germany, ranked by total equity funding and recent funding momentum. Combined disclosed equity funding of $193.2M across 20 funded companies.
| # | Company | Funding | Valuation | Stage | Latest round | Employees | Founded | Momentum |
|---|---|---|---|---|---|---|---|---|
| 1 |
LenioBio
Provider of kit for cell-free protein expression for accelerating drug delivery |
$13M | — | Series A | Grant (prize money) Jul 2025 | 18 | 2016 | ↑ Active |
| 2 |
SenseUP
Developer of microbial production strains |
$2.7M | — | Seed | Seed May 2025 | 10 | 2015 | ↑ Active |
| 3 |
PL BioScience
Manufacturer of human platelet lysate products for cell culture applications |
$13M | — | Series A | Series A Aug 2024 | 13 | 2015 | ↑ Active |
| 4 |
Singleron
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis |
$84.5M | — | Series B | Series B Nov 2021 | — | 2018 | — |
| 5 |
Cevec Pharmaceuticals
Provider of glyco-optimised human cell lines and gene therapy vectors using proprietary cell expression system |
$28.4M | — | Acquired | Series E Jul 2021 | 39 | 2001 | — |
| 6 |
Miltenyi Biotec
Develops tools and products for research and clinical application |
$12.7M | — | Funding Raised | Grant (prize money) Mar 2021 | 585 | 1989 | — |
| 7 |
Ayoxxa Biosystems
Developer of a platform for multiplex protein analysis |
$18.5M | — | Deadpooled | Grant (prize money) Jan 2017 | 40 | 2010 | — |
| 8 |
Neuway Pharma
Therapies for the treatment of brain diseases using its proprietary CNS drug delivery platform |
$7.2M | — | Public | Grant (prize money) Jun 2016 | 18 | 2014 | — |
| 9 |
LaVision BioTec
Developer of microscopes for cell analysis and preclinical imaging |
$1.3M | — | Acquired | Grant (prize money) Jan 2022 | 102 | 2000 | — |
| 10 |
Nexigen
Developer of therapies for oncological indications |
$5.9M | — | Deadpooled | Series A Jun 2011 | 10 | 2007 | — |
| 11 |
Chimera Biotec
Company offering bioanalytical services and immunoassay platforms for ultra sensitive large-molecule bioanalysis |
$1.4M | — | Funding Raised | Grant (prize money) Sep 2016 | 11 | 2001 | — |
| 12 |
Cellex
Developer of stem cells for cancer treatment |
$2M | — | Funding Raised | Grant (prize money) Mar 2010 | 127 | 2001 | — |
| 13 |
Bitop
Develops reagents for bioactive compound, cosmetic active ingredient, and biostabilizer |
$608.2K | — | Funding Raised | Grant (prize money) Jan 2018 | 41 | 1993 | — |
| 14 |
SeSaM-Biotech
Technologies and solutions for protein engineering |
$542.2K | — | Funding Raised | Grant (prize money) Jan 2017 | 5 | 2008 | — |
| 15 |
Fibrothelium
Developer of silk protein derived from silkworm cocoons |
$301.6K | — | Funding Raised | Grant (prize money) Sep 2020 | — | 2017 | — |
| 16 |
Evoxx Technologies
Developer of enzymes and bio-catalytic processes |
$553.8K | — | Acquired | Grant (prize money) Jan 2015 | 15 | 2006 | — |
| 17 |
Axel Semrau
Developer of system solutions and analytical instruments for laboratories |
$251.4K | — | Acquired | Grant (prize money) Mar 2020 | 50 | 1981 | — |
| 18 |
Aachen Proteineers
Provider of functional coating solutions |
$16.3K | — | Funding Raised | Grant (prize money) Aug 2023 | — | 2019 | — |
| 19 |
NUMAFERM
Developer of recombinant antimicrobial and adhesive peptides |
$113.9K | — | Seed | Grant (prize money) Feb 2019 | 11 | 2017 | — |
| 20 |
Autodisplay Biotech
Biotechnology company commercializing its proprietary expression platform for the display of heterologous proteins |
$55.4K | — | Funding Raised | Grant (prize money) Aug 2019 | 6 | 2008 | — |
| 21 |
Plasmid Factory
Contract developer and manufacturer of Plasmid DNA |
— | — | Public | PE Sep 2022 | 31 | 2000 | — |
| 22 |
aquila biolabs
Developer of cell density monitoring platform for shake flasks |
— | — | Seed | Seed Nov 2015 | 4 | 2014 | — |
| 23 |
PS Biotech
Enabling high-throughput screenings under fed-batch conditions |
— | — | Series A | Series A Nov 2014 | 12 | 2013 | — |
| 24 |
m2p-labs
Bioreactors for screening and bioprocess development |
— | — | Acquired | Series A Nov 2013 | 107 | 2005 | — |
| 25 |
Cysal
Biotechnological production of dipeptides |
— | — | Seed | Seed Nov 2012 | 2 | 2012 | — |
| 26 |
KonTEM
Provider of phase plates and phase contrast systems for transmission electron microscopy |
— | — | Acquired | Seed Apr 2012 | 9 | 2011 | — |
| 27 |
Taconic Artemis
Developer of Genetically engineered mouse models (GEMMs) for research purposes |
— | — | Acqui-Hired | Grant (prize money) Nov 2008 | 524 | 2007 | — |
| 28 |
Cilian
Provider of ciliate-based production platform for therapeutic proteins |
— | — | Seed | Seed 2004 | 23 | 2001 | — |
| 29 |
Acus Laboratories
Provider of high-resolution molecular target information to improve drug discoveries |
— | — | Unfunded | — | — | 2018 | — |
| 30 |
AgroProtect
Provider of agricultural consultation, data protection, and newsletter marketing services |
— | — | Funding Raised | — | — | 2010 | — |
| 31 |
Barkey
Manufacturer of medical and lab products |
— | — | Acquired | — | 33 | 1996 | — |
| 32 |
Biolabels
Develops fluorophores |
— | — | Unfunded | — | — | 2001 | — |
| 33 |
BlueSens
Gas analyzer for bio processing |
— | — | Unfunded | — | — | 2001 | — |
| 34 |
CellSystems
3D cell culture systems for primary cells and stem cells |
— | — | Unfunded | — | — | 1992 | — |
| 35 |
Cires
Provider of antibody development services |
— | — | Deadpooled | — | — | 2001 | — |
| 36 |
Evorion Biotechnologies
Developer of cell culture systems |
— | — | Unfunded | — | 17 | 2018 | — |
| 37 |
FASTGenomics
Provider of AI-based cell analysis and data management |
— | — | Unfunded | — | — | 2016 | — |
| 38 |
FBI Science
Provider of solutions and products for behavioral and experimental research |
— | — | Unfunded | — | — | 2005 | — |
| 39 |
Genekam
Products for research and diagnostics |
— | — | Unfunded | — | — | 2011 | — |
| 40 |
Haemochrom Diagnostica
Manufacturer of diagnostic products for hemostasis, thrombosis, and pyrogen analysis |
— | — | Unfunded | — | — | 1992 | — |
| 41 |
Intavis
Manufacturer of instruments and related products for laboratory analysis applications |
— | — | Unfunded | — | — | — | — |
| 42 |
Kisker Biotech
Manufactures Consumables |
— | — | Unfunded | — | — | 1990 | — |
| 43 |
Luminartis
Develops reagents and markers |
— | — | Unfunded | — | — | 2008 | — |
| 44 |
MERLIN Diagnostika
Provider of microbial identification and antimicrobial susceptibility testing products |
— | — | Acquired | — | 32 | 1990 | — |
| 45 |
Microboss Hightech
Provider of PCR kits for veterinary and agricultural science applications |
— | — | Unfunded | — | — | 2004 | — |
| 46 |
MICROBOSS Nanomedicine
Developer of nanotechnology-based products |
— | — | Unfunded | — | — | 1999 | — |
| 47 |
Mnemoscience
Designs, develops, manufactures, and commercializes biocompatible shape memory polymers |
— | — | Deadpooled | — | — | 1998 | — |
| 48 |
multiBIND biotec
Develops solutions for decontamination and disinfection |
— | — | Funding Raised | — | — | 2005 | — |
| 49 |
MultiSynTech
Developer of instruments for peptide synthesis |
— | — | Unfunded | — | — | 1997 | — |
| 50 |
Nippon Genetics
Provider of reagents, kits, and instrument systems for molecular biology |
— | — | Unfunded | — | — | 2004 | — |
Provider of kit for cell-free protein expression for accelerating drug delivery. The company develops ALiCE is the first eukaryotic cell-free protein expression platform for the discovery, development, and production of difficult-to-express proteins. It has active energy regeneration and has components necessary for protein folding, disulfide bonding, and glycosylation.
SenseUp is a developer of microbial production strains. The company uses patented meta sensor technology to screen strains of bacteria, with higher productivity. The technology has applications for train development, SNP identification, library screening, and process dynamics analysis. It also offers a product like amino acids, proteins and peptides, RNA and other natural products.
Manufacturer of human platelet lysate products for cell culture applications. The company offers a range of platelet lysate products with different safety grades. These products support cell expansion for research, therapeutics, and clinical applications. The company's technology aims to provide solutions for cell culture needs.
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis. It offers a product portfolio that includes instruments, microfluidic devices, reagents, software analysis, and database solutions that facilitate high-throughput single-cell analysis. It also, offers single cell sequencing services.
Provider of glyco-optimized human cell lines and gene therapy vectors using proprietary cell expression system. The company has ELEVECTA technology for AAV manufacturing, CAP Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for tailor-made glycosylation of recombinant proteins. Provides the CAP GT expression platform, a scalable production system for gene therapy vectors. Al
Develops tools and products for research and clinical application. The company offers biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation, cell culture, molecular analysis, clinical application, and imaging. They have expertise in immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis.
Ayoxxa Biosystems developed a technology platform for multiplexed protein analysis. The company's proprietary platform includes Lunaris BioChip that is used to identify and quantify proteins, including markers for cancer, allergies, cardiovascular or infectious diseases. It can be useful in biomedical research, pharmacological screening, and preclinical diagnostics development. The company also offers disease-specifi
Neuway Pharma, a spin-off from Life Science Inkubator is focussed on the preclinical and clinical development of therapies for the treatment of orphan brain diseases based on its proprietary CNS drug delivery platform. With its technology platform, it is developing an alternative transportation system to the CNS which has the potential to protect the human brain from toxins and inhibits the penetration of drug molecu
LaVision BioTec develops microscopes for cell analysis and preclinical imaging. The products of the company include light sheet microscope for fluorescence imaging, horizontal photon laser scanning microscope, modular 2-photon microscope platform, the doubleheader microscope, endomicroscope, etc. The products have their applications on various therapeutic segments such as neuroscience, immunology, oncology, and devel
Nexigen is developing drugs with a focus on oncological indications. They have developed a proprietary screening technology, NexiScreen, which identifies disease relevant protein-protein interactions and detects target interacting peptides. Their lead candidate, NexC1004, which acts through the hedgehog signaling pathway. The candidate is being investigated for various malignancies.
Chimera Biotec has developed a proprietary immunoassay platform called Imperacer for ultra-sensitive large molecule bioanalysis. The company claims to be the world's leading Immuno-PCR (IPCR) based technology vendor. The company's products include the Imperacer Workstation, Assay Development Kits and maintenance kit. Services offered include assay development, method validation, and bioanalysis.
Cellex is developing stem cells for cancer treatment in collaboration with GEMoaB Monoclonals. They have developed their universal CAR technology (UniCAR) where immune cells are taken and modified with a surface protein known as chimeric antigen receptor (CAR-T).
Europa
HTGF
Kfw
Creathor Venture
HHS
S-UBG
Sirius Venture Partners
TechVision Fonds
b.value AG
Bmbf
Brightlands Venture Partners
EIC Fund
Rankings are computed by Radar (Fliar BI) from the Radar company master and are updated periodically. Funding and momentum scores use disclosed equity-funding data only. Figures may lag private rounds. Last updated 2026-06-26.
_1576845297366.png){kind=logo}
_1575981928380.png){kind=logo}
